COVID-19 pandemisi öncesinde ve sırasında tiroid ince iğne aspirasyon sitolojisi sonuçlarının karşılaştırılması: pandeminin etkisi

Year 2022, Volume: 47 Issue: 4, 1471 - 1476, 28.12.2022

Süleyman Altıntaş Mehmet Bayrak

https://doi.org/10.17826/cumj.1152618

Abstract

Amaç: Bu çalışmanın amacı pandemi öncesi ve pandemi sırasında tiroid sitolojisi tanı kategorilerinin dağılımını ve toplam tiroid ince iğne aspirasyon sitoloji sayılarını Bethesda sınıflaması kullanılarak karşılaştırmaktır.
Gereç ve Yöntem: Bu çalışma iki dönem olarak planlanmıştır: (1) pandemi öncesi 15 Mart 2018 -29 Şubat 2020; (2) pandemi dönemi ise 1 Mart 2020-12 Mart 2022 tarihlerini içermekte idi. Her dönem 24 aydan oluşuyordu. Pandemi öncesi ve pandemi döneminde yapılan toplam tiroid ince iğne aspirasyon sitolojisi sayısı ve histopatolojik veriler hastane veri tabanından elde edildi.
Bulgular: Pandemi öncesi dönemde 432, pandemi sırasında 351 tiroid ince iğne aspirasyon biyopsisi yapıldı. Pandemi öncesi ve pandemi sırasında tiroid ince iğne aspirasyon sitolojisi yapılan hastalarda yaş ve cinsiyet açısından anlamlı bir fark yok idi. Bethesda sınıflamasına göre pandemi öncesi ve pandemi sırasında benign sitolojiler sırasıyla %70.8 (n:306) ve %59,0 (n:207) idi. Bethesda sınıflamasına göre, malign lezyonlar pandemi öncesi ve pandemi sırasında sırasıyla %4.4(n:19) ve %9.1(n:32) idi. Pandemi sırasında, pandemi öncesine göre anlamlı olarak daha çok malign lezyon tespit edildi.
Sonuç: Pandemi döneminde, pandemi öncesi döneme göre Bethesda sınıflamasına göre tiroid ince iğne aspirasyon sitolojisi sonuçlarında malign lezyonlar anlamlı olarak daha fazla saptandı.

Keywords

Tiroid FNA, Bethesda sınıflaması, COVID-19

Comparison of thyroid fine needle aspiration cytology results before and during the COVID-19 pandemic: the impact of the pandemic

Abstract

Purpose: The aim of this study was to compare the Bethesda classification to report the distribution of thyroid cytology diagnostic categories and total thyroid fine needle aspiration cytology numbers before and during the pandemic.
Materials and Methods: This study was planned in two phases: (1) before the pandemic, from March 15, 2018, and 29 February 2020, and during the pandemic period, from 1 March 2020 to 12 March 2022. Each period consisted of 24 months. The total number of thyroid fine needle aspiration cytology performed before the pandemic and during the pandemic dates and histopathological data were obtained from the hospital database.
Results: 432 thyroid fine needle aspiration biopsies were performed in the pre-pandemic period and 351 during the pandemic. There was no significant difference considering age and gender in patients who underwent thyroid fine needle aspiration cytology before and during the pandemic. According to the Bethesda classification, those who were benign were 70.8% (n:306) and 59.0% (n:207) respectively before pandemia and during the pandemia. According to the Bethesda classification, malignant lesions were 4.4%(n:19), and 9.1%(n:32) before and during the pandemia, respectively. During the pandemic, malignant lesions were detected significantly more than before the pandemic.
Conclusion: Malignant lesions were detected significantly more in the thyroid fine needle aspiration cytology results according to the Bethesda classification during the pandemic period compared to before the pandemic period.

Keywords

Thyroid FNA, Bethesda classification, COVID-19

References

• Referans1.M. Li, R.C. Marquez, K.L. Vinales, P.D. Reaven, G. Behari, A. Dildeep, et al. Considerations for thyroid fine needle aspiration (FNA) biopsies during the COVID-19 pandemic. Clin. Thyroidol.2020; 32: 156–58.
• Referans2.A. Vrachimis, I. Iakovou, E. Giannoula, L. Giovanella. Endocrinology in the time of COVID-19: management of thyroid nodules and cancer. Eur. J. Endocrinol. 2020; 183: 41–48.
• Referans3.D.N. Poller, S.J. Johnson, M. Bongiovanni. Measures to reduce diagnostic error and improve clinical decision making in thyroid FNA aspiration cytology: a proposed framework. Cancer Cytopathol. 2020; 128 :917-27.
• Referans4.G. Russ, S.J. Bonnema, M.F. Erdogan, C. Durante, R. Ngu, L. Leenhardt. European Thyroid Association Guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: the EU-TIRADS. Eur. Thyroid J. 2017;6:225–37.
• Referans5.Y.K. Lee, K.H. Park, Y.D. Song, T. Youk, J.Y. Nam, S.O. Song, et al. Changes in the diagnostic efficiency of thyroid fine-needle aspiration biopsy during the era of increased thyroid cancer screening in Korea. Cancer Res. Treat. 2019; 51:1430–36.
• Referans6.B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, et al. 2015 American Thyroid Association Management Guidelines for Adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26: 1–133.
• Referans7.J.-Y. Peng, F.-S. Pan, W. Wang, Z. Wang, Q.-Y. Shan, J.-H. Lin et al. Malignancy risk stratification and FNA recommendations for thyroid nodules:acomparisonofACR TI-RADS, AACE/ACE/AME, and ATA guidelines. Am. J. Otolaryngol.2020; 41: 102625.
• Referans8.Burch HB, Burman KD, Cooper DS, Hennessey JV, Vietor NO. A 2015 Survey of Clinical Practice Patterns in the Management of Thyroid Nodules. J Clin Endocrinol Metab. 2016 ;101:2853-62.
• Referans9.. R. Negro, R. Attanasio, F. Grimaldi, A. Frasoldati, R. Guglielmi, E. Papini. A 2016 Italian survey about guidelines and clinical management of thyroid nodules. Eur. Thyroid J. 2017;6: 75–81.
• Referans10.C. Bellevicine, E. Vigliar, G. Troncone. Thyroid FNA in the time of coronavirus: the interventional cytopathologist point of view. Cancer Cytopathol. 2020; 128: 589.
• Referans11.G Troncone. Thyroid cytology in the times of coronavirus. Diagn Cytopathol. 2021;49:467-68.
• Referans12.Cibas ES, Ali SZ 2009 The Bethesda System for Reporting Thyroid Cytopathology. Thyroid 19:1159–1165.
• Referans13.Cibas ES, Ali SZ; NCI Thyroid FNA State of the Science Conference. The Bethesda System For Reporting Thyroid Cytopathology. Am J Clin Pathol. 2009 ;132:658-65.
• Referans14.Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2009 ;19:1159-65.
• Referans15.C. Bellevicine, I. Migliatico, R. Sgariglia, M. Nacchio, E. Vigliar, P. Pisapia et al. Evaluation of BRAF, RAS, RET/PTC, and PAX8/ PPARg alterations in different Bethesda diagnostic categories: a multicentric prospective study on the validity of the 7‐gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy. Cancer Cytopathol. 2020;128: 107–18.
• Referans16.Poller DN, Stelow EB, Yiangou C. Thyroid FNAC cytology: can we do it better? Cytopathology. 2008; 19:4-10.
• Referans17.Cai XJ, Valiyaparambath N, Nixon P, Waghorn A, Giles T, Helliwell T. Ultrasound-guided fine needle aspiration cytology in the diagnosis and management of thyroid nodules. Cytopathology. 2006;17:251-6.
• Referans18.Robinson IA, Cozens NJA. Does a joint ultrasound-guided cytology clinic optimize the cytological evaluation of head and neck masses?. Clin Radiol. 1999;54: 312–6.
• Referans19.Kojic Katovic S, Halbauer M, Tomic-Brzac H. Importance of FNAC in the detection of tumors within multinodular goiter of the thyroid. Cytopathology. 2004;15:206–11.
• Referans20.Palladino R, Migliatico I, Sgariglia R, Nacchio M, Iaccarino A, Malapelle U, et al. Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic. Endocrine. 2021;71:20-5.
• Referans21.. D. Zhang, Y. Fu, L. Zhou, N. Liang, T. Wang, P. Del Rio, et al. Thyroid surgery during coronavirus-19 pandemic phases I, II and III: lessons learned in China, South Korea, Iran, and Italy. J. Endocrinol. Investig. 202;44:1065-73.
• Referans22.V.H. Tsang, M. Gild, A. Glover, R. Clifton-Bligh, B.G. Robinson, Thyroid cancer in the age of COVID-19. Endocr. Relat. Cancer.2020;27:407–16.
• Referans23.E. Vigliar, A. Iaccarino, D. Bruzzese, U. Malapelle, C. Bellevicine, G. Troncone. Cytology in the time of coronavirus disease (covid-19): an Italian perspective. J. Clin. Pathol. 2021;74:261-63.